Nothing Special   »   [go: up one dir, main page]

AR058107A1 - Azodicarbonamida micronizada, su preparacion y su utilizacion - Google Patents

Azodicarbonamida micronizada, su preparacion y su utilizacion

Info

Publication number
AR058107A1
AR058107A1 ARP060104569A ARP060104569A AR058107A1 AR 058107 A1 AR058107 A1 AR 058107A1 AR P060104569 A ARP060104569 A AR P060104569A AR P060104569 A ARP060104569 A AR P060104569A AR 058107 A1 AR058107 A1 AR 058107A1
Authority
AR
Argentina
Prior art keywords
azodicarbonamide
micronized
preparation
equal
less
Prior art date
Application number
ARP060104569A
Other languages
English (en)
Original Assignee
Phar H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phar H filed Critical Phar H
Publication of AR058107A1 publication Critical patent/AR058107A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

Azodicarbonamida (ADA), bajo la forma de un polvo seco micronizado, caracterizada porque dicho polvo presenta una distribucion granulométrica de partículas en donde las partículas del polvo presentan un diámetro medio (d50) igual o inferior a 2 mm, y un diámetro en el 90% (d90) igual o inferior a 4 mm, su procedimiento de preparacion y su utilizacion.
ARP060104569A 2005-10-26 2006-10-19 Azodicarbonamida micronizada, su preparacion y su utilizacion AR058107A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05110022 2005-10-26

Publications (1)

Publication Number Publication Date
AR058107A1 true AR058107A1 (es) 2008-01-23

Family

ID=36001004

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104569A AR058107A1 (es) 2005-10-26 2006-10-19 Azodicarbonamida micronizada, su preparacion y su utilizacion

Country Status (13)

Country Link
US (1) US20070110815A1 (es)
EP (1) EP1824456A2 (es)
JP (1) JP2009515830A (es)
CN (1) CN101296689A (es)
AR (1) AR058107A1 (es)
AU (1) AU2006307886A1 (es)
BR (1) BRPI0617741A2 (es)
CA (1) CA2627608A1 (es)
IL (1) IL191067A0 (es)
NO (1) NO20082079L (es)
PE (1) PE20070529A1 (es)
TW (1) TW200730170A (es)
WO (1) WO2007048820A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2460460A (en) * 2008-05-30 2009-12-02 Production Chemical Internat H Use of azodicarbonamide for reducing sulphides in a fluid
EP2213299B1 (fr) 2009-01-29 2015-09-09 Michel Vandevelde Composition vaccinale à base de virus exhibant une protéine à motif(s) en doigt de zinc, son procédé de préparation et son utilisation
CN102850243B (zh) * 2012-09-24 2013-12-11 杭州海虹精细化工有限公司 一种粒径均匀的adc发泡剂的制备方法
CN102964275A (zh) * 2012-12-06 2013-03-13 杭州海虹精细化工有限公司 一种超细粒径adc发泡剂的制备方法
CN107773759A (zh) * 2016-08-31 2018-03-09 瑞普（天津）生物药业有限公司 砂砾在提高药物生物利用度中的用途
CN108276309B (zh) * 2018-03-23 2020-08-07 湖南工业大学 一种发泡剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543607A1 (de) * 1966-07-29 1969-09-18 Bayer Ag Verfahren zur Herstellung von Azodicarbonamid
GB1404910A (en) * 1973-07-13 1975-09-03 Peroxide Catalysts Ltd Dispersible azodicarbonamide
JPS6422851A (en) * 1987-07-17 1989-01-25 Sumitomo Electric Industries Production of azodicarbonamide fine particles
JPH02142836A (ja) * 1988-11-24 1990-05-31 Eiwa Kasei Kogyo Kk 発泡剤用アゾジカルボンアミド及びその改質方法
EP0524961B1 (fr) * 1990-04-19 1994-07-06 Previsan S.A. Derives azoiques, compositions pharmaceutiques et desinfectantes les contenant et leurs utilisations contre le sida
US5585367A (en) * 1990-04-19 1996-12-17 Previsan S.A. Method of treating humans and animals infected with viruses of the retrovirus group
EP0817711A1 (en) * 1995-03-31 1998-01-14 Exxon Chemical Patents Inc. Foamed rotationally molded articles
WO1998010772A1 (fr) * 1996-09-13 1998-03-19 Previsan Ag Procede d'inhibition de biosynthese de triphosphate de desoxyribonucleotide
BE1011571A3 (fr) * 1997-11-26 1999-11-09 Hubriphar Procede d'inhibition de la production cellulaire de cytokines.
DE19932157A1 (de) * 1999-07-13 2001-01-18 Pharmasol Gmbh Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
DE102004013797A1 (de) * 2004-03-20 2005-10-06 Bayer Chemicals Ag Feste Treibmittelpräparationen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
TW200730170A (en) 2007-08-16
IL191067A0 (en) 2008-12-29
CN101296689A (zh) 2008-10-29
US20070110815A1 (en) 2007-05-17
WO2007048820A3 (fr) 2007-07-05
CA2627608A1 (fr) 2007-05-03
AU2006307886A1 (en) 2007-05-03
JP2009515830A (ja) 2009-04-16
BRPI0617741A2 (pt) 2011-08-02
EP1824456A2 (fr) 2007-08-29
NO20082079L (no) 2008-07-17
WO2007048820A2 (fr) 2007-05-03
PE20070529A1 (es) 2007-06-21

Similar Documents

Publication Publication Date Title
HK1160010A1 (en) Dried milled granulate and methods
AR058107A1 (es) Azodicarbonamida micronizada, su preparacion y su utilizacion
WO2015051054A3 (en) Benefit agent containing delivery particle based on styrene maleic anhydride copolymer
MX336930B (es) Formulaciones de ganaxolona y metodos para la manufactura y el uso de las mismas.
MX367260B (es) Tabletas de rucaparib de dosificación elevada.
RS52421B (en) RAZAGILIN FORMULATION WITH DELAYED RELEASE
WO2009050217A3 (en) Improved pharmaceutical dry powder compositions for inhalation
TW201613646A (en) Cellulose micropowder
AU323335S (en) Funnel
EP2571486A4 (en) DRY POWDER INHALATION COMPOSITION
MX2019004322A (es) Polvos secos antifungicos.
PL2183328T3 (pl) Wodne preparaty pigmentowe z dodatkami niejonowymi na bazie allilu i eteru winylowego
NZ598427A (en) Stabilized amorphous forms of imatinib mesylate with cyclodextrin complex
CO6410281A2 (es) Suspensiones acuosas de riluzol
AU325543S (en) Bottle
PE20131016A1 (es) Suspension pesticida de base acuosa
WO2011005440A3 (en) Aggregate particles of titanium dioxide for solar cells
AU319276S (en) Castor
JP2012528941A5 (es)
WO2011134962A3 (en) Orally disintegrating tablet containing acarbose
UA110484C2 (ru) Целюлозний матеріал, такий як тютюн, що містить один або декілька розріджувачів диму
MX2016017142A (es) Dispersion solida de allisartan isoproxilo y composicion farmaceutica que comprende la misma.
GB201210060D0 (en) Composition
MX2013008120A (es) Composicion cosmetica fotoprotectora de rayos ultravioleta.
TWI799735B (zh) 奈米複合材料顆粒及其用途

Legal Events

Date Code Title Description
FB Suspension of granting procedure